Amoebic liver abscess screening: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for ''[[Entamoeba histolytica]]'' infection. | |||
==Screening== | ==Screening== | ||
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for ''[[Entamoeba histolytica]]'' infection. | According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for ''[[Entamoeba histolytica]]'' infection. | ||
Revision as of 16:43, 7 February 2017
|
Amoebic liver abscess Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Amoebic liver abscess screening On the Web |
|
American Roentgen Ray Society Images of Amoebic liver abscess screening |
|
Risk calculators and risk factors for Amoebic liver abscess screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Overview
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Entamoeba histolytica infection.
Screening
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Entamoeba histolytica infection.